Gastric Sleeve vs Gastric Bypass — Which Is Right For You? (2026 Evidence-Based Comparison)

For most patients evaluating bariatric surgery, the choice narrows quickly to two procedures: gastric sleeve (vertical sleeve gastrectomy, VSG) or gastric bypass (Roux-en-Y, RYGB). They are the two most performed bariatric operations worldwide, both produce durable weight loss, and both are routinely available at Obesity Baja Point (OBP) in Tijuana. The honest answer to “which one should I choose” is rarely “both are the same.” It depends on your reflux history, your BMI, whether you have type 2 diabetes, and your tolerance for long-term nutritional management.

This evidence-based 2026 guide walks through the five-year clinical trial data, the cost difference in Tijuana, the tradeoffs no marketing page will tell you about, and a clear decision framework. It is medically reviewed and built on randomized trials — not opinions.

Gastric sleeve vs gastric bypass — quick comparison (2026)

Read on for the evidence behind each row, the decision framework, and how to talk through your case with our 24/7 international AI bariatric assistant.

What is gastric sleeve (VSG)?

Laparoscopic vertical sleeve gastrectomy is a minimally invasive procedure in which approximately 75–80% of the stomach is permanently removed. The remaining stomach is a narrow tube the diameter of a 36–40 French bougie. Weight loss occurs through two mechanisms:

• Mechanical restriction — the gastric tube holds 100–150 mL versus a normal stomach’s 1–1.5 liters.
• Hormonal effect — the gastric fundus (removed) produces most of the body’s ghrelin (the “hunger hormone”). Ghrelin levels drop after surgery, reducing appetite.

Sleeve gastrectomy is currently the most performed bariatric procedure worldwide. For a full deep-dive on cost, process, and recovery, see our 2026 gastric sleeve guide.

What is gastric bypass (Roux-en-Y, RYGB)?

Roux-en-Y gastric bypass creates a small gastric pouch (~30 mL) at the top of the stomach. The small intestine is then divided and rearranged so that food bypasses the lower stomach, duodenum, and first part of the jejunum — reaching the digestive enzymes from the pancreas and liver further downstream. Weight loss occurs via:

• Restriction — the small pouch limits volume per meal.
• Malabsorption — less surface area for nutrient absorption.
• Hormonal changes — altered gut peptide signaling (GLP-1, PYY, ghrelin).

RYGB was historically the “gold standard” bariatric procedure for several decades and remains the operation of choice for patients with severe GERD or higher BMI. The procedure is technically reversible but rarely reversed in practice. Learn more on our gastric bypass page or our forthcoming Gastric Bypass in Tijuana 2026 Cost & Process Guide.

Weight loss — what 5-year RCTs actually show

Three major randomized clinical trials compared sleeve vs bypass with at least five years of follow-up. Their results, summarized:

Honest read of the data: bypass produces 5–9 percentage points more excess weight loss at five years. For most patients (BMI 35–45), that translates to roughly 10–25 extra pounds lost — meaningful but not transformational. The decision should not rest on this gap alone. Long-term adherence to diet, exercise, and follow-up matters more than the procedure choice within this range.

For patients with starting BMI > 50, the modest extra weight loss from bypass becomes more meaningful — and many surgeons recommend bypass or even SADI-S as the first-line choice in that population.

Type 2 diabetes — which procedure puts it in remission?

If you have type 2 diabetes alongside obesity, the metabolic effect of bariatric surgery may matter more than the weight loss itself. The landmark STAMPEDE trial at the Cleveland Clinic followed patients for five years and reported HbA1c ≤ 6.0%:

• 23% of sleeve gastrectomy patients reached HbA1c ≤ 6.0% [4]
• 29% of gastric bypass patients reached the same target [4]
• Only 5% of patients on intensive medical therapy alone reached it [4]

The procedure-to-procedure gap (6 percentage points) is real but smaller than the surgery-vs-medication gap (24 percentage points). Both bariatric procedures dramatically outperform intensive medical management for T2DM remission.

That said, bypass’s edge in T2DM — particularly for patients with longer disease duration or insulin dependence — is well established in subgroup analyses. If your endocrinologist describes your diabetes as “poorly controlled” or “insulin-dependent,” bypass deserves serious consideration.

GERD — the critical decider

Gastroesophageal reflux disease (GERD) is the single most important variable in this decision, and the topic competitors often soft-pedal in pursuit of the simpler “sleeve” pitch.

The 2024 SleeveBypass RCT reported:

• 16% of sleeve patients developed de novo GERD by five years post-op [9]
• 4% of bypass patients developed de novo GERD by five years post-op [9]

The mechanism: sleeve gastrectomy alters the angle of His and reduces the lower esophageal sphincter’s ability to prevent reflux. Bypass, by contrast, diverts acid-producing stomach tissue away from the food pathway, often improving pre-existing reflux.

The 10-year SLEEVEPASS extension data published in JAMA Surgery reinforces this trend even more strongly: at the 10-year follow-up, esophagitis was present in 31% of sleeve patients vs only 7% of bypass patients [11]. Barrett’s esophagus rates remained similar between groups (4% each), but the long-term reflux burden of sleeve gastrectomy is now well documented.

Practical implication:

• If you have no GERD currently and no Barrett’s esophagus, either procedure is appropriate.
• If you have mild, well-controlled GERD, sleeve is still possible but discuss the risk of worsening with your surgeon.
• If you have moderate-to-severe GERD requiring daily PPIs, hiatal hernia, or Barrett’s esophagus, gastric bypass is the procedure of choice. Don’t accept a sleeve in this scenario without a very thorough conversation.

Cost in Tijuana — sleeve vs bypass at OBP (2026)

All-inclusive package pricing at Obesity Baja Point in 2026:

The $1,000–$3,000 price difference between sleeve and bypass at OBP reflects the additional surgical complexity (two anastomoses vs zero), longer operating time, and slightly extended hospital observation. Both packages include the same components: surgeon’s fee, hospital + OR + anesthesia, 2-night hospital stay, pre-op labs and EKG performed in Tijuana, post-op medications, airport/CBX transportation, 2–3 recovery hotel nights with bariatric meals, and 12 months of video follow-ups.

Don’t let the cost gap decide for you. A $2,000 difference is small in the context of a permanent surgical decision that affects the next 30–40 years of your life. The right procedure for your medical fit will save vastly more in long-term healthcare costs.

Long-term supplementation & nutritional management

Both procedures require lifelong supplementation. The protocols differ:

After sleeve gastrectomy

• Bariatric multivitamin (daily)
• Vitamin B12 (sublingual or injection, lifelong)
• Calcium citrate (1,200–1,500 mg/day, split doses)
• Vitamin D3 (2,000–3,000 IU/day)
• Iron only if labs show deficiency (less common than after bypass)

After gastric bypass

• Bariatric multivitamin (daily, often higher dose)
• Vitamin B12 (lifelong, often injection)
• Calcium citrate (1,500–2,000 mg/day, split doses)
• Vitamin D3 (3,000–5,000 IU/day)
• Iron (45–60 mg/day, often required for premenopausal women)
• Closer lab monitoring — annual checks of B12, ferritin, folate, vitamin D, calcium, PTH, magnesium, zinc, copper

The bypass supplementation regimen is not catastrophic, but it is real, lifelong, and non-negotiable. Patients who consistently skip supplements after bypass risk anemia, osteoporosis, neurological symptoms from B12 deficiency, and protein malnutrition. The sleeve is more forgiving in this respect.

Decision framework — which procedure for which patient

Talk this through with your surgeon and the OBP assistant, but these are the patterns we see clinically:

Sleeve gastrectomy is the better fit when:

• BMI 35–45 without severe metabolic disease
• No or mild reflux that is well controlled
• You prefer simpler anatomy and lower long-term supplementation burden
• You have a history of intestinal disease (Crohn’s, severe diverticulitis) that makes intestinal rerouting risky
• You may want a future revision option (sleeve → bypass → SADI-S is a recognized pathway)

Gastric bypass is the better fit when:

• Moderate-to-severe GERD, hiatal hernia, or Barrett’s esophagus
• Uncontrolled type 2 diabetes, especially insulin-dependent
• Starting BMI > 50 where the modest extra weight loss matters
• Higher tolerance for lifelong nutritional monitoring
• You accept dumping syndrome as a manageable downside

Other procedures to consider

• Mini-gastric bypass (one-anastomosis) — simpler bypass alternative, growing in Europe. Discuss with your surgeon if you want bypass-like results with reduced surgical complexity.
• SADI-S / duodenal switch — for BMI > 50 or severe T2DM. Maximum weight loss procedure, also the highest supplementation burden.
• Intragastric balloon — non-surgical option for BMI 27–35 or patients who are not yet ready for surgery. Reversible, 6-month placement.

Bone health — an under-discussed long-term divergence

One area patient counseling often skips: bone density loss. Both procedures cause some bone mineral density (BMD) loss, but bypass causes more.

The Oseberg randomized controlled trial measured BMD at one year and found:

• RYGB caused significantly greater BMD loss than sleeve at the lumbar spine (−4.2%), femoral neck (−2.8%), and total hip (−3.0%) [12]
• Bone turnover markers (P1NP, CTX-1) roughly doubled after RYGB compared with sleeve [12]

A 2022 systematic review and meta-analysis of 14 studies (n = 717 patients) found that long-term areal BMD was not significantly different between RYGB and sleeve — meaning the body partially compensates over time — but bone turnover markers stayed elevated longer after bypass, suggesting greater fragility risk [13].

Practical implication: If you are a postmenopausal woman, have a family history of osteoporosis, or already have low baseline BMD, the bypass’s bone effects matter more. Add calcium citrate + vitamin D + weight-bearing exercise to your protocol, and ask your primary care to monitor DEXA at year 1, year 3, and every 2-3 years thereafter.

If your sleeve fails — conversion to bypass

A large 2023 analysis of the MBSAQIP registry found that 13.7% of Roux-en-Y gastric bypasses in 2020–2021 were CONVERSIONS from a prior sleeve — out of 97,975 RYGB procedures, more than 13,000 were revision conversions [14]. The top indications:

• GERD — 55.3% of conversions [14]
• Weight regain — 24.4%
• Inadequate weight loss — 12.7%

That registry also found that serious complication rates of conversion RYGB are modestly higher than primary RYGB (7.2% vs 5.0%) — not catastrophic, but worth knowing in advance.

Technical details:

• The sleeve tube becomes the “pouch” in a now-Roux-en-Y configuration
• Surgical complexity is higher than primary bypass — expect 120–180 minutes
• Patients typically lose an additional 15–25% of regained excess weight

OBP performs revision conversions regularly. The 2026 all-inclusive cost for sleeve-to-bypass revision in Tijuana is approximately $7,500–$9,500 USD, depending on adhesions and prior surgical history.

Is the surgery cost-effective long-term?

Beyond the up-front package price, peer-reviewed economic analyses have looked at lifetime cost effectiveness. A 2022 JAMA Network Open study modeled severe obesity with type 2 diabetes over a 5-year horizon and found:

• Roux-en-Y gastric bypass had an incremental cost-effectiveness ratio (ICER) of $46,877 per QALY versus medical therapy alone [15]
• For mild T2D, the ICER dropped to $36,479 per QALY, making bypass strongly cost-effective [15]
• Patients gained on average 0.44 quality-adjusted life years versus medical management [15]

By the U.S. willingness-to-pay benchmark of $50,000–$100,000 per QALY, both gastric sleeve and gastric bypass are economically reasonable choices — even at full U.S. self-pay prices. At Tijuana prices (~70% lower), the cost-effectiveness math becomes overwhelming.

A note on mini-gastric bypass (OAGB)

One-anastomosis gastric bypass (OAGB), sometimes called “mini-bypass,” is a simpler bypass variant gaining popularity in Europe and Latin America. The YOMEGA randomized trial compared OAGB vs Roux-en-Y bypass at 2 years and found:

• Non-inferior weight loss: percent excess BMI loss −87.9% (OAGB) vs −85.8% (RYGB) [16]
• Significantly higher nutritional adverse events after OAGB: 21.4% vs 0% for RYGB (P = 0.0034) [16]

OAGB delivers comparable weight loss with a simpler operation, but the nutritional tradeoff is real. OBP offers mini-gastric bypass for selected candidates — ask the assistant if this option fits your case.

Frequently asked questions

Which is cheaper at OBP in Tijuana — sleeve or bypass?

Gastric sleeve at OBP is $5,200–$7,500 USD all-inclusive. Gastric bypass is $6,500–$8,500 USD all-inclusive. The $1,000–$3,000 difference reflects surgical complexity. Both packages include surgeon, hospital, anesthesia, transport, recovery hotel, and 12-month follow-up.

Which procedure produces more weight loss?

Bypass produces about 5–9 percentage points more excess weight loss at five years across three large randomized trials [2][3][9]. For most patients (BMI 35–45), this translates to 10–25 extra pounds — meaningful but not transformative.

I have acid reflux — should I still consider sleeve?

If your reflux is mild and well-controlled, sleeve is still possible — with a thorough surgical evaluation. If your reflux is moderate-to-severe, requires daily PPIs, or you have a hiatal hernia or Barrett’s esophagus, gastric bypass is strongly preferred. De novo GERD develops in 16% of sleeve patients vs 4% of bypass patients at five years [9].

Which is better for type 2 diabetes?

Both are vastly superior to medication alone. STAMPEDE at 5 years: HbA1c ≤ 6.0% in 23% of sleeve patients, 29% of bypass patients, only 5% on intensive medical therapy [4]. Bypass has a small edge for severe, longer-duration, or insulin-dependent T2DM.

Can I switch from sleeve to bypass later?

Yes. Sleeve-to-bypass conversion is a well-established revision pathway, used for weight regain or persistent GERD. OBP performs these routinely. 2026 all-inclusive cost: $7,500–$9,500 USD.

Which has faster recovery?

Sleeve. Most patients return to desk work in 7–10 days vs 10–14 days for bypass. Total surgical time is also shorter (60–90 min vs 90–150 min), and hospital stay is comparable (2 nights) for both at OBP.

What about “dumping syndrome” — should I worry?

Dumping is a real consideration after bypass. Eating concentrated sugars or large meals can cause nausea, sweating, palpitations, and diarrhea about 30–60 minutes later. Most patients adapt within 6–12 months. Sleeve patients rarely experience true dumping.

How is the procedure performed?

Both are laparoscopic (minimally invasive), performed under general anesthesia, with 4–5 small abdominal incisions. Sleeve uses a stapler to resect the lateral stomach. Bypass uses staplers to create a small pouch + divide the intestine, then joins (anastomoses) the two ends to form the Y configuration.

Will I need supplements forever?

Yes — both procedures. Sleeve: bariatric multivitamin + B12 + calcium + vitamin D. Bypass: same plus iron and more frequent lab monitoring. This is non-negotiable for long-term health.

References

1. Eisenberg D, et al. 2022 ASMBS/IFSO Indications for Metabolic and Bariatric Surgery. Obesity Surgery. 2023. DOI: 10.1007/s11695-022-06332-1 · PMID 36336720
2. Salminen P, et al. SLEEVEPASS Randomized Clinical Trial: 5-Year Outcomes. JAMA. 2018. DOI: 10.1001/jama.2017.20313 · PMID 29340676
3. Peterli R, et al. SM-BOSS Randomized Clinical Trial: 5-Year Outcomes. JAMA. 2018. JAMA 319(3):255-265 · PMID 29340679
4. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes (STAMPEDE). New England Journal of Medicine. 2017. DOI: 10.1056/NEJMoa1600869 · PMID 28199805
5. Osti N, et al. Six-year analysis of 30-day post-operative leaks for primary sleeve gastrectomy: a MBSAQIP database study. Surgical Endoscopy. 2024. DOI: 10.1007/s00464-024-11190-2 · PMID 39218833
6. Juodeikis Z, Brimas G. Long-term results after sleeve gastrectomy: a systematic review. Surgery for Obesity and Related Diseases. 2017. PMID 27876332
7. Grönroos S, et al. Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass (SleeveBypass). The Lancet Regional Health – Europe. 2024. DOI: 10.1016/j.lanepe.2024.100823 · PMID 38313139
8. Salminen P, Grönroos S, Helmiö M, et al. Effect of Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years (SLEEVEPASS 10-Year). JAMA Surgery. 2022. DOI: 10.1001/jamasurg.2022.2229 · PMID 35731535
9. Hofsø D, Hillestad TOW, Halvorsen E, et al. Bone Mineral Density and Turnover After Sleeve Gastrectomy and Gastric Bypass: Oseberg Randomized Controlled Trial. J Clin Endocrinol Metab. 2021. DOI: 10.1210/clinem/dgaa808 · PMID 33150385
10. Gu L, Lin K, Du C, et al. Effects of Gastric Bypass and Sleeve Gastrectomy on Bone Mineral Density: Systematic Review and Meta-Analysis. World Journal of Surgery. 2022. DOI: 10.1007/s00268-021-06429-1 · PMID 35006326
11. Dang JT, Vaughan T, Mocanu V, et al. Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: Indications, Prevalence, and Safety. Obesity Surgery. 2023. DOI: 10.1007/s11695-023-06546-x · PMID 36922465
12. Lauren BN, Lim F, Krikhely A, et al. Estimated Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and Gastric Bypass in Patients With Severe Obesity and Type 2 Diabetes. JAMA Network Open. 2022. DOI: 10.1001/jamanetworkopen.2021.48317 · PMID 35157054
13. Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA). The Lancet. 2019. DOI: 10.1016/S0140-6736(19)30475-1 · PMID 30851879

Medical disclaimer: this article is provided for educational purposes only and does not constitute personalized medical advice. The choice between gastric sleeve and gastric bypass depends on individual factors including BMI, comorbidities, reflux history, and personal preference. All candidates must undergo formal medical evaluation. Talk to a qualified bariatric surgeon to determine which procedure is appropriate for your case. Last medically reviewed: 2026.